Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06774703 · ClinicalTrials.gov registry record
Nemaline Myopathy Clinical Research Network (NM-CTRN)
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 50
- Enrollment target
NCT06774703: Clinical Trial study, sponsored by Stanford University.
NCT06774703 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06774703 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-01 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06774703
The ClinicalTrials.gov registry entry for NCT06774703 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06774703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06774703 about?
NCT06774703 is a clinical study titled "Nemaline Myopathy Clinical Research Network (NM-CTRN)". The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).
What is the current status of trial NCT06774703?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2025-01. Estimated completion is 2029-12.
Who is sponsoring clinical trial NCT06774703?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.